ROS proto‐oncogene 1, receptor tyrosine kinase (ROS 1), and anaplastic lymphoma kinase (ALK) rearrangements are present in approximately 2% and 5% of non‐small cell lung cancers (NSCLCs), respectively. The gene discussed is ALK; the disease is lung cancer.